|
| ID |
DDInter460 |
| Drug Type |
small molecule |
| Molecular Formula |
C9H13N3O5 |
| Molecular Weight |
243.219
|
| Description |
Cytarabine is a pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia.
|
| ATC Classification |
L01BC01
L01XY01
|
| IUPAC Name |
4-Amino-1-[(2R,3S,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-1,2-Dihydropyrimidin-2-One |
| InChI |
Inchi=1S/C9H13N3O5/C10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/H1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/T4-,6-,7+,8-/M1/S1 |
| InChI Key |
UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
| Canonical SMILES |
NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|